These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effective Prevention and Management of Tumor Lysis Syndrome in Children With Cancer: The Important Contributions of Pediatric Oncology Nurses. Li HC; Chung OK; Tam CJ; Chiu SY J Pediatr Oncol Nurs; 2015; 32(4):209-18. PubMed ID: 25556106 [TBL] [Abstract][Full Text] [Related]
6. Management of tumor lysis syndrome in adults. Coiffier B; Riouffol C Expert Rev Anticancer Ther; 2007 Feb; 7(2):233-9. PubMed ID: 17288532 [TBL] [Abstract][Full Text] [Related]
7. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266 [TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis and differential therapy of tumorlysis syndrome]. Krych M; Dreyling M; Kneba M; Hoelzer D; Hiddemann W; Hallek M Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1440-5. PubMed ID: 15213877 [No Abstract] [Full Text] [Related]
9. Targeting tumor lysis syndrome: new therapeutic options. Shonkwiler E ONS News; 2006; 21(8 Suppl):49-50. PubMed ID: 16925150 [No Abstract] [Full Text] [Related]
10. [Pharmacological and clinical profile of rasburicase (Rasuritek)]. Ohno K; Tawara K Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):255-60. PubMed ID: 20543517 [No Abstract] [Full Text] [Related]
11. [Malignant hemopathies and tumor lysis syndrome: a current topic]. Leverger G; Le Guyader N Arch Pediatr; 2005 Oct; 12 Spec No 1():1-3. PubMed ID: 17076002 [No Abstract] [Full Text] [Related]
12. [Single-dose rasburicase as treatment for tumor lysis syndrome in two patients]. Ferrandis Rodríguez P; Llinares Tello F; Burgos San José A; Moscardó Guilleme C An Pediatr (Barc); 2006 Jun; 64(6):603-4. PubMed ID: 16792976 [No Abstract] [Full Text] [Related]
13. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Jones GL; Will A; Jackson GH; Webb NJ; Rule S; Br J Haematol; 2015 Jun; 169(5):661-71. PubMed ID: 25876990 [No Abstract] [Full Text] [Related]
14. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel. Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of the 2015 British guidelines on the prevention and management of tumor lysis syndrome]. Dupré A; Mousseaux C; Bouguerba A; Ayed S; Barchazs J; Boukari M; Goldgran-Toledano D; Bornstain C; Vincent F; Rev Med Interne; 2017 Jan; 38(1):36-43. PubMed ID: 27659746 [TBL] [Abstract][Full Text] [Related]